MARKET

MEDXF

MEDXF

Medexus Pharmace
OTCQX
1.910
+0.020
+1.06%
Closed 15:58 12/05 EST
OPEN
1.910
PREV CLOSE
1.890
HIGH
1.910
LOW
1.910
VOLUME
300
TURNOVER
573
52 WEEK HIGH
3.880
52 WEEK LOW
1.450
MARKET CAP
38.47M
P/E (TTM)
114.37
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MEDXF last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at MEDXF last week (1117-1121)?
Weekly Report · 11/24 10:04
Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares
Newsfile · 11/20 12:30
Medexus Pharmaceuticals Secures US$51 Million Credit Facilities with National Bank of Canada
Reuters · 11/17 13:34
Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
Newsfile · 11/17 13:30
Weekly Report: what happened at MEDXF last week (1110-1114)?
Weekly Report · 11/17 10:04
Medexus Pharmaceuticals reports FQ2 results
Seeking Alpha · 11/13 16:16
Medexus Pharma Q2 revenue misses estimates
Reuters · 11/12 23:17
More
About MEDXF
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of hematology-oncology and allergy, dermatology, and rheumatology. It operates through two product portfolios: Medexus Pharma Canada and Medexus Pharma. Its lead products are IXINITY (US), GRAFAPEX (US), Trecondyv (Canada), Rupall (Canada), Rasuvo (US), Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Webull offers Medexus Pharmaceuticals Inc stock information, including OTCQX: MEDXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDXF stock methods without spending real money on the virtual paper trading platform.